4//SEC Filing
PRYGOCKI MARK A SR 4
Accession 0000899243-22-021761
CIK 0001817944other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 8:06 PM ET
Size
7.5 KB
Accession
0000899243-22-021761
Insider Transaction Report
Form 4
PRYGOCKI MARK A SR
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-07+4,805→ 4,805 totalExercise: $0.43Exp: 2032-06-06→ Common Stock (4,805 underlying) - Award
Common Stock
2022-06-07+1,922→ 5,766 total
Footnotes (2)
- [F1]The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 1,922 shares on 06/07/2022, which vests in full at the earlier of June 7, 2023 or the next annual meeting subject to the Reporting Person having a service relationship as of each such vesting.
- [F2]These options were granted under the 2021 Plan and vest in full at the earlier of June 7, 2023 or the next annual meeting subject to the Reporting Person having a service relationship as of each such vesting.
Documents
Issuer
Clarus Therapeutics Holdings, Inc.
CIK 0001817944
Entity typeother
Related Parties
1- filerCIK 0001257544
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 8:06 PM ET
- Size
- 7.5 KB